)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Sensei Biotherapeutics
Sensei Biotherapeutics (SNSE) investor relations material
Sensei Biotherapeutics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary10 Jun, 2026
Company overview and business model
Clinical-stage biotechnology company focused on multi-node inhibition of oncogenic pathways to improve cancer patient outcomes.
Acquired Faeth Therapeutics in February 2026, adding PIKTOR, an all-oral combination therapy targeting the PI3K/AKT/mTOR pathway, to its pipeline.
Lead program PIKTOR is in Phase 2 for endometrial cancer and Phase 1b for HR+/HER2- advanced breast cancer.
Pipeline includes additional antibody programs and assets from both pre- and post-acquisition portfolios.
Financial performance and metrics
Raised approximately $200 million in gross proceeds from a private placement of Series B Preferred Stock at $13,850 per share ($13.85 per share on an as-converted-to-common basis).
Financial statements for 2024 and 2025 audited by Deloitte & Touche LLP.
Use of proceeds and capital allocation
No proceeds will be received from the resale of shares by selling stockholders; proceeds from warrant exercises, if any, will go to the company.
Company will bear registration and listing costs, while selling stockholders cover their own transaction expenses.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sensei Biotherapeutics
- Registering 24.9M shares for resale after Faeth acquisition and $200M private placement.SNSE
Registration filing2 Jun 2026 - Board changes and governance updates set for June 2026, pending stockholder approval.SNSEProxy filing22 May 2026
- Stockholders to vote on major capital structure changes following Faeth acquisition and PIPE financing.SNSEProxy filing21 May 2026
- $170.2M Q1 loss, $202.8M cash after $200M raise; PIKTOR trials advance amid going concern risk.SNSEQ1 202615 May 2026
- Biotech registers 24.9M shares for resale after acquisition and $200M private placement.SNSERegistration filing28 Apr 2026
- Shareholders to vote on director elections, major share increase, and new equity plans.SNSEProxy filing27 Apr 2026
- Shareholders to vote on major proposals enabling Faeth acquisition, recapitalization, and new equity plans.SNSEProxy filing27 Apr 2026
- Major acquisition, share issuance, and board changes proposed; key votes to reshape governance.SNSEProxy filing16 Apr 2026
- Oral multi-node inhibition shows promising efficacy and safety in advanced solid tumors.SNSE25th Annual Needham Virtual Healthcare Conference16 Apr 2026
Next Sensei Biotherapeutics earnings date
Q2 20265 Aug, 2026
Sensei Biotherapeutics
Next Sensei Biotherapeutics earnings date
Q2 20265 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage